Epstein Becker Green adds FDA specialist to team


Neil Di Spirito has left Ballard Spahr to join Epstein Becker Green as a member of the firm’s healthcare and life sciences practice.

Epstein Becker Green, Neil Di Spirito, Ballard Spahr, Food and Drug Administration, market approval, licensing agreements, labelling, advertising, pharma